home All News open_in_new Full Article

Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi

Collaboration leverages City Therapeutics’ next-generation RNAi engineering technologies and Biogen’s extensive drug development expertise CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced a strategic collaboration to develop select novel RNAi therapies. Through […]


today 3 w. ago attach_file Sport

attach_file Events
attach_file Other
attach_file Sport
attach_file Politics
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Society
attach_file Other
attach_file Other
attach_file Other
attach_file Economics
attach_file Other
attach_file Events
attach_file Politics
attach_file Other
attach_file Other
attach_file Economics


ID: 1490334711
Add Watch Country

arrow_drop_down